Page last updated: 2024-08-26

fulvestrant and gw9662

fulvestrant has been researched along with gw9662 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, K; Xu, JW; Yamori, Y1
Glazer, RI; Kopelovich, L; Lu, J; Yin, Y; Yuan, H1

Other Studies

2 other study(ies) available for fulvestrant and gw9662

ArticleYear
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:9

    Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents

2004
Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy.
    Oncotarget, 2012, Volume: 3, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Anilides; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinogens; Carcinoma; Chemoprevention; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Mice; Microarray Analysis; Molecular Targeted Therapy; PPAR gamma

2012